Replimune Group, Inc. (REPL) Stock Forecast 2026: P10, P50 & P90 — Probabli.AI
Timestamped REPL stock forecast with 1-year P10, P50, and P90 price estimates, scenario probabilities, definitions, sources, and limitations.
Direct answer: Replimune Group, Inc., currently priced at $11.47, is showing promising developments in its oncolytic virus therapy pipeline, supported by positive trial results and significant funding. However, regulatory challenges and cautious analyst sentiment present headwinds. The stock's one-year outlook is moderately cautious, given current assessments, but there are substantial long-term growth prospects if key developments materialize successfully. Investors should watch for trial advancements, regulatory updates, and potential strategic collaborations to better gauge future performance. The saved 1-year distribution is P10 $8.6, P50 $10, and P90 $13.5.
Last analyzed · Model: gpt-4o
Replimune Group, Inc. Forecast data
| Estimate | 1-year price | Meaning |
|---|
| P10 | $8.6 | Pessimistic plausible scenario |
| P50 | $10 | Median scenario |
| P90 | $13.5 | Optimistic plausible scenario |
What the numbers mean
P10, P50, and P90 are model-generated scenario estimates: roughly a pessimistic plausible outcome, a median outcome, and an optimistic plausible outcome. They are not calibrated confidence intervals.
Supporting analysis
Replimune's recent positive headlines surrounding its pipeline and funding provide optimism. However, the analyst consensus and price targets suggest caution. The regulatory setback reported is a potential downside risk, contributing to mixed expectations for the year ahead.
Sources and limitations
Market and company inputs are primarily sourced through Yahoo Finance and public financial-data interfaces. This page reports a saved AI-generated scenario analysis as of the timestamp above; it is not live data, audited probability, financial advice, or a guaranteed return.
Frequently asked questions
When was this REPL analysis generated?
July 6, 2026.
Is this a guaranteed REPL prediction?
No. It is a model-generated scenario assessment with material uncertainty.
View the full REPL stock analysis · REPL sentiment · Methodology · Accuracy & validation
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.